Secukinumab (anti-IL-17A)Secukinumab (anti-IL-17A)
Move your mouse over image or click to enlarge

Secukinumab (anti-IL-17A)

Secukinumab (anti-IL-17A) (Cosentyx, AIN457) is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A, and is applied for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. MW=147.9 kDa.
Cat# Size Price Qty Buy
A2025-5mg 5mg £579.00

Additional Information

Property Value or Rating
Product Size 5mg
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2025

Related Documents